BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salvatore D, Buzzetti R, Baldo E, Furnari ML, Lucidi V, Manunza D, Marinelli I, Messore B, Neri AS, Raia V. An overview of international literature from cystic fibrosis registries. Part 4: update 2011. J Cyst Fibros. 2012;11:480-493. [PMID: 22884375 DOI: 10.1016/j.jcf.2012.07.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Salvatore D, Buzzetti R, Mastella G. An overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease: Cystic Fibrosis Lung Disease in Patient Registries. Pediatr Pulmonol 2016;51:1251-63. [DOI: 10.1002/ppul.23473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Amoureux L, Bador J, Fardeheb S, Mabille C, Couchot C, Massip C, Salignon AL, Berlie G, Varin V, Neuwirth C. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates. Appl Environ Microbiol 2013;79:7142-9. [PMID: 24038696 DOI: 10.1128/AEM.02293-13] [Cited by in Crossref: 51] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
3 Hortencio TD, Nogueira RJ, Marson FA, Hessel G, Ribeiro JD, Ribeiro AF. [Factors impacting the growth and nutritional status of cystic fibrosis patients younger than 10 years of age who did not undergo neonatal screening]. Rev Paul Pediatr 2015;33:3-11. [PMID: 25681074 DOI: 10.1016/j.rpped.2014.11.004] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Hampton TH, Green DM, Cutting GR, Morrison HG, Sogin ML, Gifford AH, Stanton BA, O'Toole GA. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome 2014;2:14. [PMID: 25071935 DOI: 10.1186/2049-2618-2-14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
5 Langawi MA, Byrnes C, Davies JC, Hamouda S, Kabra M, Rached SZ, Sands D, Shteinberg M, Taylor-Cousar J, Tullis E, Wainwright C. 'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020. J Cyst Fibros 2020;19:184-93. [PMID: 32156627 DOI: 10.1016/j.jcf.2020.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nightingale JA, Osmond C. Does current reporting of lung function by the UK cystic fibrosis registry allow a fair comparison of adult centres? J Cyst Fibros 2017;16:585-91. [PMID: 28462874 DOI: 10.1016/j.jcf.2017.04.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
7 Gensburger D, Boutroy S, Chapurlat R, Nove-Josserand R, Roche S, Rabilloud M, Durieu I. Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients. Osteoporos Int 2016;27:2803-13. [PMID: 27165286 DOI: 10.1007/s00198-016-3612-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Haack A, Aragão GG, Novaes MRCG. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol 2013; 19(46): 8552-8561 [PMID: 24379572 DOI: 10.3748/wjg.v19.i46.8552] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
9 Oglesby IK, Agrawal R, Mall MA, McElvaney NG, Greene CM. miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6. Mol Cell Pediatr 2015;2:1. [PMID: 26542291 DOI: 10.1186/s40348-014-0012-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
10 Tournier A, Murris M, Prevotat A, Fanton A, Bettiol C, Parinaud J. Fertility of women with cystic fibrosis: a French survey. Reprod Biomed Online 2019;39:492-5. [PMID: 31256948 DOI: 10.1016/j.rbmo.2019.04.128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Quintana-Gallego E, Ruiz-Ramos M, Delgado-Pecellin I, Calero C, Soriano JB, Lopez-Campos JL. Mortality from cystic fibrosis in Europe: 1994-2010. Pediatr Pulmonol 2016;51:133-42. [PMID: 26584153 DOI: 10.1002/ppul.23337] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Miller AC, Harris LM, Cavanaugh JE, Abou Alaiwa M, Stoltz DA, Hornick DB, Polgreen PM. The rapid reduction of infection-related visits and antibiotic use among people with cystic fibrosis after starting Elexacaftor-Tezacaftor-Ivacaftor. Clin Infect Dis 2022:ciac117. [PMID: 35142340 DOI: 10.1093/cid/ciac117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Nony P, Kurbatova P, Bajard A, Malik S, Castellan C, Chabaud S, Volpert V, Eymard N, Kassai B, Cornu C; CRESim., Epi-CRESim. A methodological framework for drug development in rare diseases. Orphanet J Rare Dis 2014;9:164. [PMID: 25774598 DOI: 10.1186/s13023-014-0164-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
14 Smith DJ, Ramsay KA, Yerkovich ST, Reid DW, Wainwright CE, Grimwood K, Bell SC, Kidd TJ. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres. Respirology 2016;21:329-37. [PMID: 26711802 DOI: 10.1111/resp.12714] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
15 Salvatore D, Buzzetti R, Mastella G. Update of literature from cystic fibrosis registries 2012-2015. Part 6: Epidemiology, nutrition and complications: Non-Pulmonary Topics From Cystic Fibrosis Registries. Pediatr Pulmonol 2017;52:390-8. [DOI: 10.1002/ppul.23611] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
16 Tunes A, Reis JN, Terse R, Santana MA, Diniz AL, Barros TF, Leal AK, Paixão V, Grassi MF. Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia - Brazil. Braz J Infect Dis 2014;18:215-9. [PMID: 24275368 DOI: 10.1016/j.bjid.2013.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Taylor-Robinson D, Schlüter DK, Diggle PJ, Barrett JK. Explaining the Sex Effect on Survival in Cystic Fibrosis: a Joint Modeling Study of UK Registry Data. Epidemiology 2020;31:872-9. [PMID: 32841985 DOI: 10.1097/EDE.0000000000001248] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Casserly P, Harrison M, O’connell O, O’donovan N, Plant BJ, O’sullivan P. Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group. Eur Arch Otorhinolaryngol 2015;272:3353-9. [DOI: 10.1007/s00405-014-3446-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Lima TRL, Guimarães FS, Sá Ferreira A, Penafortes JTS, Almeida VP, Lopes AJ. Correlation between posture, balance control, and peripheral muscle function in adults with cystic fibrosis. Physiotherapy Theory and Practice 2013;30:79-84. [DOI: 10.3109/09593985.2013.820246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
20 Taylor-Robinson D, Archangelidi O, Carr SB, Cosgriff R, Gunn E, Keogh RH, MacDougall A, Newsome S, Schlüter DK, Stanojevic S, Bilton D; CF-EpinNet collaboration. Data Resource Profile: The UK Cystic Fibrosis Registry. Int J Epidemiol 2018;47:9-10e. [PMID: 29040601 DOI: 10.1093/ije/dyx196] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
21 Billings JL, Dunitz JM, McAllister S, Herzog T, Bobr A, Khoruts A. Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps. J Clin Gastroenterol. 2014;48:e85-e88. [PMID: 24275715 DOI: 10.1097/mcg.0000000000000034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
22 Frischer T, Eber E, Ellemunter H, Zacharasiewicz A, Kaluza I, Riedler J, Renner S. Cystic fibrosis in Austria. Wien Klin Wochenschr 2017;129:527-32. [PMID: 28236043 DOI: 10.1007/s00508-017-1179-x] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C. European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis. Journal of Cystic Fibrosis 2014;13:S43-59. [DOI: 10.1016/j.jcf.2014.03.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
24 Shen Y, Liu J, Zhong L, Mogayzel PJ, Zeitlin PL, Sosnay PR, Zhao S. Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children. J Pediatr. 2016;171:269-76.e1. [PMID: 26826884 DOI: 10.1016/j.jpeds.2015.12.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
25 Elborn JS. Current Approaches to the Management of Infection in Cystic Fibrosis. Curr Pediatr Rep 2013;1:141-8. [DOI: 10.1007/s40124-013-0024-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Sanders DB, Fink AK. Background and Epidemiology. Pediatr Clin North Am 2016;63:567-84. [PMID: 27469176 DOI: 10.1016/j.pcl.2016.04.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
27 Buttini F, Rossi I, Di Cuia M, Rossi A, Colombo G, Elviri L, Sonvico F, Balducci AG. Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients. Int J Pharm 2016;502:242-8. [PMID: 26854429 DOI: 10.1016/j.ijpharm.2016.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
28 Husereau D, Henshall C, Jivraj J. Adaptive approaches to licensing, health technology assessment, and introduction of drugs and devices. Int J Technol Assess Health Care 2014;30:241-9. [PMID: 24921416 DOI: 10.1017/S0266462314000191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]